Alt Text
Office of Neuroscience Research > WUSTL Neuroscience News > NIH Weekly Funding Opportunities, Notices: August 4, 2017

NIH Weekly Funding Opportunities, Notices: August 4, 2017



Notices
Requests for Applications
Program Announcements

     

  • The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)
    (PA-17-440)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R01)
    (PA-17-443)
    National Institute on Deafness and Other Communication Disorders
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)
    (PA-17-444)
    National Human Genome Research Institute
    National Cancer Institute
    National Institute on Aging
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Deafness and Other Communication Disorders
    National Institute of Environmental Health Sciences
    National Institute on Minority Health and Health Disparities 
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)
    (PA-17-445)
    National Human Genome Research Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)
    (PA-17-446)
    National Human Genome Research Institute
    National Cancer Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Deafness and Other Communication Disorders
    National Institute of Environmental Health Sciences
    National Institute on Minority Health and Health Disparities 
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Administrative supplements for validation studies of analytical methods for dietary supplements and natural products (Admin. Suppl.)
    (PA-17-447)
    Office of Dietary Supplements
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): October 15, 2017; January 15, 2018; April 15, 2018; by 5:00 PM local time of applicant organization. 

     

  • Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R21)
    (PA-17-448)
    National Institute on Deafness and Other Communication Disorders
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)
    (PA-17-449)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Pregnancy in Women with Disabilities (R03)
    (PA-17-451)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Pregnancy in Women with Disabilities (R01)
    (PA-17-452)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • NIBIB Exploratory/Developmental Research Grant Program (R21)
    (PAR-17-441)
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt Date(s): Standard dates apply or Month(s) Day(s), Year(s), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Point of Care Technologies Research Network: Point of Care Centers (U54)
    (PAR-17-453)
    National Institute of Biomedical Imaging and Bioengineering
    John E. Fogarty International Center
    National Center for Complementary and Integrative Health
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    Office of Behavioral and Social Science Research
    Application Receipt Date(s): October 27, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.